ReviewFrontiers in microbiology2026
Molecular war and peace: the concurrent path to antibiosis and antibiotic resistance.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The possibility of the emergence of proto-antibiotic and proto-resistance molecules in the prebiotic world, as primary elements involved in "molecular wars," is examined in this conceptual review. Throughout the Earth's early history, prebiotic chemical processes produced molecules that associated both randomly and persistently. Over time, those configurations that achieved greater stability were favored, their longevity effectively serving as a mechanism for prebiotic selection. Available chemical molecules or physical surfaces could stabilize and prolong the duration of certain aggregates, creating competition among them. Hypothetically, some aggregates could yield conformations capable of disrupting the assembly or stability of rival structures, thereby acting as proto-antimolecules and later evolving into proto-antibiotics in a primitive cellular scenario. Concurrently, some other molecular aggregates may deactivate such proto-antimolecules and antibiotics, acting as primitive mechanisms of resistance. Probably, both production and protection mechanisms tended to coalesce in multimolecular assemblies, ensuring the non-self-destruction of producers. Over a prolonged period, the chemical Thioester World, RNA World, and the biological Proto-Cellular World coexisted, and proto-organelles began to be influenced and protected by proto-antibiotics and proto-resistances. Antibiotic production and resistance remained associated, even at the stage of antibiotic polyketides, which progressively emerged in a more oxygenated landscape, with early biosynthetic pathways giving rise to contemporary ones, mainly in Actinomycota. This simultaneous action-and-reaction scenario provided an ecological equilibrium in which antibiotic molecules were not necessarily killer agents but rather regulatory signals within the microbiosphere, ensuring healthy bacterial interactions. The massive anthropogenic antibiotic production altered such an equilibrium, favoring an unbalanced resistance reaction through the massive diffusion of antibiotic resistance genes, now decoupled from antibiotic production and spreading across the microbial world, mostly carried in mobile genetic elements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.